Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vanda Pharmaceuticals (NQ: VNDA )

10.43 +0.10 (+0.97%)
Streaming Delayed Price Updated: 1:00 PM EST, Nov 25, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 146,133
Open 10.29
Bid (Size) 4.230 (1)
Ask (Size) 11.00 (2)
Prev. Close 10.33
Today's Range 10.21 - 10.53
52wk Range 9.240 - 18.00
Shares Outstanding 55,638,166
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Earnings Scheduled For November 2, 2022
Companies Reporting Before The Bell • Nomura Holdings (NYSE:NMR) is likely to report earnings for its second quarter. 
Via Benzinga
Looking Into Vanda Pharmaceuticals's Return On Capital Employed
  
Via Benzinga

Performance

YTD
-36.98%
-36.98%
1 Month
-0.38%
-0.38%
3 Month
+1.76%
+1.76%
6 Month
+2.05%
+2.05%
1 Year
-36.98%
-36.98%

More News

Read More
Recap: Vanda Pharma Q2 Earnings
Via Benzinga
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Earnings Scheduled For May 5, 2022
Via Benzinga
Earnings Outlook For Vanda Pharmaceuticals
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 25, 2022
Via Benzinga
93 Biggest Movers From Friday
Via Benzinga
10 Biggest Price Target Changes For Friday
Via Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
Via Benzinga
Vanda Pharmaceuticals: Q4 Earnings Insights
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
50 Biggest Movers From Friday
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Earnings Scheduled For February 23, 2022
Via Benzinga
Mid-Afternoon Market Update: Dow Turns Positive; Snap Shares Climb Following Upbeat Results
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Tech Earnings Prop Up Nasdaq as Bond Yields Rise
Via Talk Markets
Mid-Day Market Update: Dow Drops 100 Points; U.S. Nonfarm Payrolls Top Estimates
Via Benzinga
28 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Mid-Morning Market Update: Nasdaq Jumps 100 Points As Amazon Profit Tops Estimates
Via Benzinga
Why Are Vanda Pharma Shares Plunging Today?
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.